Analyst Ratings February 19, 2026

UBS Affirms Buy on On Holding, Cites Strong Consumer Demand and Margin Resilience

Analysts see significant upside to current share price while highlighting volatility and P&L requirements as key risks

By Sofia Navarro ONON
UBS Affirms Buy on On Holding, Cites Strong Consumer Demand and Margin Resilience
ONON

UBS has reiterated a Buy rating and set an $85.00 price target on On Holding AG (ONON), implying roughly 78% upside from the prevailing $47.77 share price. The bank's channel checks point to sustained consumer momentum and it models a modest fourth-quarter sales beat ex-currency. UBS also expects fiscal 2026 ex-currency sales growth guidance of about 23% and an adjusted EBITDA margin of 18.0% to 18.5%, supported by strong gross margins and a conservative balance sheet.

Key Points

  • UBS reaffirmed a Buy rating and $85.00 price target on On Holding, implying roughly 78% upside from the cited $47.77 share price - impacts equity investors and consumer discretionary sector sentiment.
  • UBS expects a 50-100 basis point fourth-quarter sales beat ex-currency and models fiscal 2026 ex-currency sales growth of about 23% with adjusted EBITDA margin guidance of 18.0% to 18.5% - relevant to profitability and retail revenue forecasts.
  • On Holding’s balance sheet shows more cash than debt and a current ratio of 2.55, while gross profit margin of 62.4% supports margin targets - material to creditworthiness and financial resilience.

UBS has reiterated a Buy rating on On Holding AG (NYSE: ONON) stock and maintained a price target of $85.00, which translates to an approximate 78% upside from the most recently cited share price of $47.77. The firm said its market checks point to continued strong engagement from consumers, a trend UBS expects to translate into near-term sales outperformance.

Specifically, UBS projects that On Holding will post a fourth-quarter sales result that beats expectations by 50 to 100 basis points on an ex-currency basis. That outlook is presented alongside the company’s recent top-line momentum, with revenue expanding 33.3% over the last twelve months.

Analyst consensus data from InvestingPro indicates On Holding is viewed as slightly undervalued by the analyst community, with a consensus recommendation score of 1.63 - classified as Strong Buy under that dataset.

Looking to fiscal 2026, UBS anticipates the company will reiterate an ex-currency sales growth guide of roughly 23% and will provide an adjusted EBITDA margin target in the range of 18.0% to 18.5%. UBS noted that these metrics would be in line with market expectations. Underpinning these projections is On Holding’s sustained gross profit margin, which stands at 62.4% and supports the company’s ability to reach the stated profitability thresholds.

UBS outlined what could drive upside and downside to its view. Upside could emerge if On Holding issues a fiscal 2026 top-line guide that is modestly stronger than current forecasts. Conversely, UBS warned that downside could materialize if investors demand visible strength across multiple profit-and-loss line items - including faster Americas revenue growth, improved gross margins, and tightened selling, general and administrative expenses - despite an underlying bearish sentiment among some market participants.

The firm also emphasized On Holding’s balance-sheet position as a mitigating factor. The company reported having more cash than debt and a current ratio of 2.55, offering a degree of resilience if operating conditions prove uneven.

Market-implied volatility is another consideration. Options traders are pricing in a potential share move of plus or minus 10.1%, slightly below the historical average implied move of plus or minus 10.7%. UBS concurred that shares may be subject to heightened swings, a view reinforced by the stock’s beta of 2.15, which indicates greater sensitivity to market movements compared with the broader market.

Investors should also note the near-term earnings calendar: On Holding’s next quarterly report is scheduled for March 3, which the article characterizes as just 12 days away. For market participants seeking additional analysis, InvestingPro provides a Research Report covering On Holding as part of its coverage of over 1,400 U.S. stocks.


Other analyst activity and corporate updates

Several other research houses and company developments were highlighted alongside UBS’s call. On Holding has appointed Frank Sluis as its incoming Chief Financial Officer, with his tenure set to begin in May 2026. That appointment follows the company’s decision to separate the CEO and CFO functions, roles that were previously combined under Martin Hoffmann.

On the broker side, Goldman Sachs upgraded On Holding to a Buy rating and raised its price target to $59.00. Bernstein reiterated an Outperform rating and set a $70.00 price target, citing robust operational results. Stifel maintained a Buy rating and a $60.00 price target, noting the new CFO appointment. KeyBanc lowered its price target to $58.00 while retaining an Overweight rating, attributing the change to recent stock underperformance. These varied views illustrate a range of analyst perspectives on the company’s near-term trajectory and strategic changes.

Risks

  • Downside if the market requires strength across the full P&L - including Americas revenue growth, gross margin, and SG&A - which could pressure the stock if those areas lag; this affects equity valuations in the consumer discretionary sector.
  • Near-term volatility risk with options-implied move of +/-10.1% and stock beta of 2.15 indicating elevated share-price swings; this impacts traders and portfolio managers focused on risk management.
  • Analyst divergence and recent stock underperformance could temper sentiment despite upgrades from some brokers, creating uncertain demand dynamics in the market for On Holding shares.

More from Analyst Ratings

Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026 BWS Financial Boosts A10 Networks Price Target Citing AI-Driven Network Traffic Feb 20, 2026 Supreme Court Ruling Boosts Steve Madden Outlook, Analysts Say Feb 20, 2026